AMRN Q4 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$75M-16.5% YoY

Gross Profit

$45M59.4% margin

Operating Income

-$5M-6.2% margin

Net Income

-$6M-7.7% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$651,564

Free Cash Flow

-$651,550

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$832M

Total Liabilities

$280M

Stockholders' Equity

$552M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$90M	-16.5%
Gross Profit	$45M	$64M	-29.6%
Operating Income	-$5M	-$10M	+51.5%
Net Income	-$6M	$856,000	-781.2%

Revenue Segments

Product

$71M94%

Licensing And Royalty

$4M6%